<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03345394</url>
  </required_header>
  <id_info>
    <org_study_id>FAPESP 2017/05371-8</org_study_id>
    <nct_id>NCT03345394</nct_id>
  </id_info>
  <brief_title>Effectiveness of Contingency Management in the Treatment of Crack Addiction in Brazil</brief_title>
  <official_title>Effectiveness of Contingency Management in the Treatment of Crack Addiction for Individuals Living in the &quot;Crackland&quot; Region. A Single-blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crack addiction has become a severe public health problem in Brazil. Crack users present&#xD;
      elevated prevalence rates of psychiatric comorbidities, sexual transmitted infections and&#xD;
      unemployment with high probability of living or have lived in the streets, history of&#xD;
      incarceration and engagement in illegal activities. For the last 20 years a treatment called&#xD;
      Contingency Management (CM) have achieved the best results regarding reduction of substance&#xD;
      use, promotion of abstinence, treatment attendance and retention in treatment. The first CM&#xD;
      study conducted in Brazil advocates for the efficacy of CM on all of these outcomes,&#xD;
      suggesting that CM can be effective in a Brazilian population of crack users.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the effectiveness of Contingency Management (CM)&#xD;
      for crack users living in the &quot;Crackland&quot; region. To achieve this goal, regular treatment&#xD;
      staff from Unidade Recomeço Helvétia treatment service will be capacitated in CM to latter-on&#xD;
      apply the CM intervention in their respective services. The design will be a single-blind&#xD;
      randomized clinical trial composed of a sample of 100 subjects with current diagnose for&#xD;
      crack/cocaine dependence. Participants allocated to the control condition will receive 12&#xD;
      weeks of the usual care treatment provided by these two treatment facilities. Participants&#xD;
      allocated to the experimental condition will receive the exact same treatment as control&#xD;
      participants associated with CM. CM procedure will occur 2 timer per week (every Monday and&#xD;
      Thursday or Tuesday and Friday). Primary outcomes are: (1)retention in treatment; (2)&#xD;
      reduction of crack use; (3) promotion of continuous crack cocaine abstinence. Secondary&#xD;
      findings are reduction on psychiatric symptomatology. The investigator hypothesis is that&#xD;
      participants in the CM condition will have a better treatment response in all studied&#xD;
      outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single-blind randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>researchers had no contact with participants during the 12 week trial</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pattern of Crack Cocaine Use</measure>
    <time_frame>12 weeks</time_frame>
    <description>Percentage of negative crack cocaine urine samples submitted during the 12 weeks of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Promotion of Continuous Crack Cocaine Abstinence</measure>
    <time_frame>12 weeks</time_frame>
    <description>Longest duration of continuous abstinence achieved (in weeks)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment Retention</measure>
    <time_frame>12 weeks</time_frame>
    <description>time elapsed between treatment entry and last time present in treatment (in weeks)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Substance Use Disorders</condition>
  <condition>Contingency Management</condition>
  <condition>Addiction, Cocaine</condition>
  <arm_group>
    <arm_group_label>Standard Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Contingency Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
    <arm_group_label>Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard treatment</intervention_name>
    <description>Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
    <arm_group_label>Standard Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  DSM-V diagnose for crack cocaine use disorder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  being under 18 years old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre M de Queiroz Constantino Miguel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unidade Recomeço Helvétia</name>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>01215-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <results_first_submitted>January 7, 2021</results_first_submitted>
  <results_first_submitted_qc>March 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 8, 2021</results_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>André de Queiroz Constantino Miguel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>crack cocaine</keyword>
  <keyword>contingency management</keyword>
  <keyword>ambulatory treatment</keyword>
  <keyword>Brazil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Cocaine-Related Disorders</mesh_term>
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/94/NCT03345394/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Treatment</title>
          <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program&#xD;
Standard treatment: Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
        </group>
        <group group_id="P2">
          <title>Contingency Management</title>
          <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management&#xD;
Contingency Management: Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>all participants enrolled in the study were analyzed (intention to treat)</population>
      <group_list>
        <group group_id="B1">
          <title>Standard Treatment</title>
          <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program&#xD;
Standard treatment: Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
        </group>
        <group group_id="B2">
          <title>Contingency Management</title>
          <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management&#xD;
Contingency Management: Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="98"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.2" spread="9.2"/>
                    <measurement group_id="B2" value="37.2" spread="9"/>
                    <measurement group_id="B3" value="38.7" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Negative urine exam at baseline</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pattern of Crack Cocaine Use</title>
        <description>Percentage of negative crack cocaine urine samples submitted during the 12 weeks of treatment</description>
        <time_frame>12 weeks</time_frame>
        <population>all enrolled participants were analyzed (intention to treat)</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program&#xD;
Standard treatment: Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
          </group>
          <group group_id="O2">
            <title>Contingency Management</title>
            <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management&#xD;
Contingency Management: Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
          </group>
        </group_list>
        <measure>
          <title>Pattern of Crack Cocaine Use</title>
          <description>Percentage of negative crack cocaine urine samples submitted during the 12 weeks of treatment</description>
          <population>all enrolled participants were analyzed (intention to treat)</population>
          <units>percent of negative cocaine samples</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.3" spread="4.6"/>
                    <measurement group_id="O2" value="40.7" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Promotion of Continuous Crack Cocaine Abstinence</title>
        <description>Longest duration of continuous abstinence achieved (in weeks)</description>
        <time_frame>12 weeks</time_frame>
        <population>all participants enrolled in the study were analyzed (intention to treat)</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program&#xD;
Standard treatment: Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
          </group>
          <group group_id="O2">
            <title>Contingency Management</title>
            <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management&#xD;
Contingency Management: Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
          </group>
        </group_list>
        <measure>
          <title>Promotion of Continuous Crack Cocaine Abstinence</title>
          <description>Longest duration of continuous abstinence achieved (in weeks)</description>
          <population>all participants enrolled in the study were analyzed (intention to treat)</population>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="3.4"/>
                    <measurement group_id="O2" value="4.35" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Retention</title>
        <description>time elapsed between treatment entry and last time present in treatment (in weeks)</description>
        <time_frame>12 weeks</time_frame>
        <population>all participants enrolled in the study where analyzed (intention to treat)</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Treatment</title>
            <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program&#xD;
Standard treatment: Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
          </group>
          <group group_id="O2">
            <title>Contingency Management</title>
            <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management&#xD;
Contingency Management: Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Retention</title>
          <description>time elapsed between treatment entry and last time present in treatment (in weeks)</description>
          <population>all participants enrolled in the study where analyzed (intention to treat)</population>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="4.8"/>
                    <measurement group_id="O2" value="7" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <desc>Because this study did not include a pharmacological intervention, the only adverse event information collected was mortality.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Treatment</title>
          <description>12 weeks of standard treatment offered by Unidade Recomeço Helvétia treatment program&#xD;
Standard treatment: Participants will receive the standard treatment offered at Unidade Recomeço Helvétia treatment program</description>
        </group>
        <group group_id="E2">
          <title>Contingency Management</title>
          <description>12 weeks of standard treatment offered at Unidade Recomeço Helvétia treatment program associated with Contingency Management&#xD;
Contingency Management: Participants will receive vouchers with monetary value for submitting crack cocaine negative urine samples</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. André Miguel</name_or_title>
      <organization>Federal University of Sao Paulo</organization>
      <phone>+55 11 965884111</phone>
      <email>aqcmiguel@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

